Bristol Medical School

Over a fifth of all child deaths in England could be avoided by reducing deprivation, new report finds

Around 700 child deaths that occur in England each year might be avoided by reducing deprivation, finds a new NHS England-funded report published today [13 May]. The University of Bristol National Child Mortality Database (NCMD)-led analysis identified a clear association between the risk of death and level of deprivation for children in England, for all categories of death except cancer.

GW4 takes a world leading One Health approach to tackling the antimicrobial resistance pandemic

The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities – GW4) formally launched their new ‘One Health’ antimicrobial resistance research consortium this week [Wednesday 16 June]. The World Health Organisation cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security.

Adrenal gland activity change under severe stress causing abnormal release of glucocorticoid stress hormones

To respond to stress optimally, the body needs to produce glucocorticoid hormones, such as cortisol, extremely quickly. New research by scientists from the Universities of Bristol and Exeter has revealed the molecular network that enables rapid glucocorticoid production within the adrenal glands, and has shown how the behaviour of this network can be altered under severe stress.

How have vaccines helped to protect the world and how can they continue to do so?

The power of vaccines to help save lives and shape our world has never been more evident as countries around the world fight against COVID-19. The pandemic has also highlighted how vital it is for industry, academia and global populations to work together in the race for effective vaccines. The importance of vaccine research to global public health will be discussed later this week by a distinguished panel of experts at a live online event jointly organised by the University of Bristol and Pfizer.

Combining heroin and commonly prescribed non-opioid pain killers leads to a significant rise in overdose deaths

A multi-disciplinary study has shown that the recent substantial increase in prescriptions for two drugs, pregabalin and gabapentin, used widely for a range of neurological disorders is closely correlated with a rise in the number of overdose deaths in England and Wales. These drugs have become drugs of abuse, according to new University of Bristol findings published in Addiction, which highlight that they are especially dangerous when used with heroin or other opioids